pubmed-article:15846221 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15846221 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
pubmed-article:15846221 | lifeskim:mentions | umls-concept:C1418244 | lld:lifeskim |
pubmed-article:15846221 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
pubmed-article:15846221 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
pubmed-article:15846221 | lifeskim:mentions | umls-concept:C0701303 | lld:lifeskim |
pubmed-article:15846221 | lifeskim:mentions | umls-concept:C0066772 | lld:lifeskim |
pubmed-article:15846221 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
pubmed-article:15846221 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:15846221 | pubmed:dateCreated | 2005-4-22 | lld:pubmed |
pubmed-article:15846221 | pubmed:abstractText | This study was undertaken to provide evidence for the mode of action of RU486 on glycodelin produced in K562 cells. To show that histiocytes may be a source of glycodelin in leiomyoma. | lld:pubmed |
pubmed-article:15846221 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15846221 | pubmed:language | eng | lld:pubmed |
pubmed-article:15846221 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15846221 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:15846221 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15846221 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15846221 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15846221 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15846221 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15846221 | pubmed:month | Apr | lld:pubmed |
pubmed-article:15846221 | pubmed:issn | 0002-9378 | lld:pubmed |
pubmed-article:15846221 | pubmed:author | pubmed-author:RamachandranS... | lld:pubmed |
pubmed-article:15846221 | pubmed:author | pubmed-author:Parthasarathy... | lld:pubmed |
pubmed-article:15846221 | pubmed:author | pubmed-author:MurphyAna AAA | lld:pubmed |
pubmed-article:15846221 | pubmed:author | pubmed-author:SongMing... | lld:pubmed |
pubmed-article:15846221 | pubmed:author | pubmed-author:LoweErinE | lld:pubmed |
pubmed-article:15846221 | pubmed:author | pubmed-author:DominguezCeli... | lld:pubmed |
pubmed-article:15846221 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15846221 | pubmed:volume | 192 | lld:pubmed |
pubmed-article:15846221 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15846221 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15846221 | pubmed:pagination | 1285-93; discussion 1293-4 | lld:pubmed |
pubmed-article:15846221 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:15846221 | pubmed:meshHeading | pubmed-meshheading:15846221... | lld:pubmed |
pubmed-article:15846221 | pubmed:meshHeading | pubmed-meshheading:15846221... | lld:pubmed |
pubmed-article:15846221 | pubmed:meshHeading | pubmed-meshheading:15846221... | lld:pubmed |
pubmed-article:15846221 | pubmed:meshHeading | pubmed-meshheading:15846221... | lld:pubmed |
pubmed-article:15846221 | pubmed:meshHeading | pubmed-meshheading:15846221... | lld:pubmed |
pubmed-article:15846221 | pubmed:meshHeading | pubmed-meshheading:15846221... | lld:pubmed |
pubmed-article:15846221 | pubmed:meshHeading | pubmed-meshheading:15846221... | lld:pubmed |
pubmed-article:15846221 | pubmed:meshHeading | pubmed-meshheading:15846221... | lld:pubmed |
pubmed-article:15846221 | pubmed:meshHeading | pubmed-meshheading:15846221... | lld:pubmed |
pubmed-article:15846221 | pubmed:meshHeading | pubmed-meshheading:15846221... | lld:pubmed |
pubmed-article:15846221 | pubmed:meshHeading | pubmed-meshheading:15846221... | lld:pubmed |
pubmed-article:15846221 | pubmed:meshHeading | pubmed-meshheading:15846221... | lld:pubmed |
pubmed-article:15846221 | pubmed:meshHeading | pubmed-meshheading:15846221... | lld:pubmed |
pubmed-article:15846221 | pubmed:meshHeading | pubmed-meshheading:15846221... | lld:pubmed |
pubmed-article:15846221 | pubmed:meshHeading | pubmed-meshheading:15846221... | lld:pubmed |
pubmed-article:15846221 | pubmed:meshHeading | pubmed-meshheading:15846221... | lld:pubmed |
pubmed-article:15846221 | pubmed:meshHeading | pubmed-meshheading:15846221... | lld:pubmed |
pubmed-article:15846221 | pubmed:meshHeading | pubmed-meshheading:15846221... | lld:pubmed |
pubmed-article:15846221 | pubmed:meshHeading | pubmed-meshheading:15846221... | lld:pubmed |
pubmed-article:15846221 | pubmed:meshHeading | pubmed-meshheading:15846221... | lld:pubmed |
pubmed-article:15846221 | pubmed:meshHeading | pubmed-meshheading:15846221... | lld:pubmed |
pubmed-article:15846221 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:15846221 | pubmed:articleTitle | RU486 inhibits expression of lysophosphatidic acid induced glycodelin. | lld:pubmed |
pubmed-article:15846221 | pubmed:affiliation | Emory University School of Medicine, Department of Gynecology and Obstetrics, Atlanta, GA, USA. | lld:pubmed |
pubmed-article:15846221 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15846221 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:15846221 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |